Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.78% vs 4.90% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -83.68% vs 567.09% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 40.91% vs -7.04% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -9.09% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Aurinia Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.78% vs 4.90% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 24.32% vs 24.25% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -83.68% vs 567.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 47.64% vs 317.76% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 40.91% vs -7.04% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 42.20% vs 663.79% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -9.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -9.09% vs -15.38% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






